Unveiling ANGO’s Q2 2024 Earnings: A Closer Look at AngioDynamics’ Performance
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its revenue declined. The medical device maker also provided guidance for…
Read More...
Read More...